Provided by Tiger Fintech (Singapore) Pte. Ltd.

Terns Pharmaceuticals, Inc.

3.18
-0.2700-7.83%
Post-market: 3.250.0700+2.20%19:35 EDT
Volume:1.75M
Turnover:5.70M
Market Cap:270.11M
PE:-2.70
High:3.50
Open:3.49
Low:3.16
Close:3.45
Loading ...

BUZZ-Terns Pharma rises on early data for blood cancer drug

Reuters
·
03 Dec 2024

Terns Pharmaceuticals Shares up About 6% Premarket After Co Announces Early Data for Experimental Blood Cancer Drug

THOMSON REUTERS
·
03 Dec 2024

Terns Pharmaceuticals Reports Promising Results in CML Trial

TIPRANKS
·
03 Dec 2024

Terns Pharmaceuticals announces early data from Phase 1 CARDINAL trial

TIPRANKS
·
03 Dec 2024

Terns Pharmaceuticals Inc - No Dose Limiting Toxicities or Treatment Discontinuations in Phase 1 Study for Cardinal Trial of Tern-701

THOMSON REUTERS
·
03 Dec 2024

Terns Pharmaceuticals Announces Positive Early Data From Phase 1 Cardinal Trial of Tern-701 for Chronic Myeloid Leukemia

THOMSON REUTERS
·
03 Dec 2024

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

GlobeNewswire
·
03 Dec 2024

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

GlobeNewswire
·
03 Dec 2024

BRIEF-Terns Pharmaceuticals Reports Inducement Grant To New Employee

Reuters
·
03 Dec 2024

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Dec 2024

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
03 Dec 2024

Terns Pharmaceuticals on the Brink of Innovation with Upcoming TERN-701 Data Release

TIPRANKS
·
23 Nov 2024

Terns Pharmaceuticals Appoints Heather Turner to Board

TIPRANKS
·
19 Nov 2024

Terns Pharmaceuticals Appoints Heather Turner, J.d., to Board of Directors

THOMSON REUTERS
·
19 Nov 2024

Press Release: Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

Dow Jones
·
19 Nov 2024

Steven Cohen's Strategic Acquisition in Terns Pharmaceuticals Inc

GuruFocus
·
16 Nov 2024